In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Fate Therapeutics Inc (NASDAQ: FATE) closed at $1.12 up 2.75% from its previous closing price of $1.09. In other words, the price has increased by $2.75 from its previous closing price. On the day, 8.67 million shares were traded.
Ratios:
For a deeper understanding of Fate Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.29 and its Current Ratio is at 8.29. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.25.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 10 ’25 when Bressi Jerome Charles sold 5,980 shares for $1.55 per share. The transaction valued at 9,269 led to the insider holds 270,203 shares of the business.
TAHL CINDY sold 5,654 shares of FATE for $8,764 on Jan 10 ’25. The insider now owns 336,707 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, Valamehr Bahram, who serves as the President and CEO of the company, sold 8,705 shares for $1.54 each. As a result, the insider received 13,406 and left with 349,364 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.48 while its Price-to-Book (P/B) ratio in mrq is 0.35.
Stock Price History:
Over the past 52 weeks, FATE has reached a high of $8.83, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -22.94%, while the 200-Day Moving Average is calculated to be -61.80%.
Shares Statistics:
A total of 113.88M shares are outstanding, with a floating share count of 97.88M. Insiders hold about 14.06% of the company’s shares, while institutions hold 81.33% stake in the company.
